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be useful in clinical practice.
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ABSTRACT
BACKGROUND AND PURPOSE: Automated volumetry of the hippocampus is considered useful to assist the diagnosis of hippo-
campal sclerosis in temporal lobe epilepsy. However, voxel-based morphometry is rarely used for individual subjects because of
high rates of false-positives. We investigated whether an approach with high dimensional warping to the template and nonpara-
metric statistics would be useful to detect hippocampal atrophy in patients with hippocampal sclerosis.
MATERIALS AND METHODS: We performed single-subject voxel-based morphometry with nonparametric statistics within the
framework of Statistical Parametric Mapping to compare MRI from 26 well-characterized patients with temporal lobe epilepsy indi-
vidually against a group of 110 healthy controls. The following statistical threshold was used: P, .05 corrected for multiple compar-
isons with family-wise error over the region of interest right and left hippocampus.
RESULTS: The sensitivity for the detection of atrophy related to hippocampal sclerosis was 0.92 (95% CI, 0.67–0.99) for the right
hippocampus and 0.60 (0.31–0.83) for the left, and the specificity for volume changes was 0.98 (0.93–0.99). All clusters of decreased
hippocampal volumes were correctly lateralized to the seizure focus. Hippocampal volume decrease was in accordance with neuro-
nal cell loss on histology reports.
CONCLUSIONS: Nonparametric voxel-based morphometry is sensitive and specific for hippocampal atrophy in patients with mesial tem-
poral lobe epilepsy and may be useful in clinical practice.
ABBREVIATIONS: TLE ¼ temporal lobe epilepsy; VBM ¼ voxel-based morphometry; TIV ¼ total intracranial volume; ILAE ¼ International League Against
Epilepsy; DARTEL ¼ Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra; MAP ¼ Morphometric Analysis Program; ROC ¼ Receiver oper-
ating characteristic curves; AUC ¼ area under the curve; SnPM ¼ Statistical non Parametric Mapping; HS ¼ hippocampal sclerosis; FLAIR ¼ fluid attenuated
inversion recovery; EEG ¼ electroencephalography
V
oxel-based morphometry (VBM) is a powerful automated
tool to investigate cerebral gray matter changes, based on
high-resolution structural MR imaging.1 It has been used to dem-
onstrate network atrophy in temporal lobe epilepsy (TLE)2-4 and
neuroplasticity in pain conditions, such as medication-overuse
headache,5 and in learning.6
While inference from VBM studies is mostly based on group
comparisons, information for the individual subject would be of
great clinical value. The use of VBM for single subjects however
is limited by a high rate of false-positive findings.7 Recent studies
demonstrate that this problem can be overcome with the use of
nonparametric statistics.8
TLE is the most frequent among the focal epilepsies. The
most common underlying pathology in patients with temp-
oral lobe epilepsy is mesial temporal sclerosis characterized by
selective hippocampal neuronal loss and gliosis.9 In medically
refractory TLE, hippocampal atrophy is associated with a favorable
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outcome after epilepsy surgery10 and in a large epilepsy surgery se-
ries, hippocampal sclerosis was the most frequent finding.9 Thus,
identification of hippocampal sclerosis (HC) is of high clinical rele-
vance during presurgical evaluation. A previous study found that
VBM was not sensitive to cortical neuronal loss and hippocampal
sclerosis in individual patients.11 Voxel-based automated analyses
have rarely been used for the detection of hippocampal sclerosis in
the individual.12-14 Recent methodologic advances, such as the use
of a high-dimensional warping to the template brain, are likely to
improve sensitivity of VBM.15
The aim of our study was to evaluate the potential role of
VBM for the detection of hippocampal atrophy in individual
epilepsy patients, by using high-dimensional warping and
nonparametric statistics in a clinical setting. This was done
by comparing well-characterized individual patients with
known hippocampal sclerosis against a large normal data
base from healthy controls, estimating sensitivity and speci-
ficity. Specifically, we studied whether subjects with known
hippocampal atrophy and healthy controls were correctly
assigned by the automated algorithm.
MATERIALS AND METHODS
Overview
The study was approved by the ethics committee of the Medical
University of Vienna. The conduct of the study is in accordance
with the Declaration of Helsinki. In brief, hippocampal volumes
were estimated automatically, based on high-resolution 3D struc-
tural MR imaging scans. Hippocampal volumes were assessed by
1) comparing individual MR imaging scans against a large nor-
mal data base from healthy controls, by using VBM and nonpara-
metric statistics that automatically detect voxels with gray matter
changes; 2) plotting estimates of extracted hippocampal volumes
from individual patients with temporal lobe epilepsy against the
healthy control data base.
Patients with Epilepsy and Healthy Control MR Imaging
Data Base
The present retrospective analysis includes high-resolution MR
imaging scans from 26 patients with TLE (5 patients from the
Karl Landsteiner Institute of Clinical Epilepsy Research, acquired
on a 3T Achieva scanner (Philips), termed “3T VIE,” and 21
patients from the Medical University Vienna, acquired on a 1.5T
Gyroscan (Philps), termed “1.5T VIE” from a previous study that
are fully described therein),2 fulfilling the following criteria (all
inclusion criteria and none of the exclusion criteria): 1) Patients
with drug-resistant epilepsy, ie, those who had a failure of
adequate trials of 2 tolerated, appropriately chosen and used anti-
epileptic drug schedules (monotherapy or combination) to
achieve persistent seizure freedom.16 2) Diagnosis of TLE defined
by typical clinical seizure semiology, interictal and ictal EEG find-
ings documented during video-EEG monitoring. 3) Patients had
undergone high-resolution T1-weighted volume MR imaging
sequences of the brain (eg, MPRAGE). Exclusion criteria: 1)
Lesions in the brain, except hippocampal sclerosis. 2) Significant
vascular comorbidity or vascular risk factors such as uncontrolled
hypertension. Demographic and clinical data including MR
imaging findings are summarized in the On-line Table. Mean age
was 38.2 6 13.0 years (range 18–60), 13 were women. Definition
of the criterion standard (hippocampal sclerosis, side) was based
on the following: An expert panel consisting of neurologists, neu-
roradiologists, and neurosurgeons reached a consensus on the di-
agnosis and the side of seizure focus, based on clinical semiology,
ictal and interictal electroencephalography (EEG), and a dedi-
cated MR imaging epilepsy protocol. Histology data and postsur-
gical outcome were available in the 20/26 patients who had had
an operation.
Healthy controls were recruited by using local advertisements
at the research sites and screened by senior neurologists. Our
healthy control data base comprised high-resolution 3D T1-
weighted sequences from the Karl Landsteiner Institute of
Clinical Epilepsy Research and Cognitive Neurology, Vienna
(acquired on “3T VIE,” n ¼ 44) and from previous studies at the
Institute for Biomedical Engineering, University and ETH Zurich
(acquired on a 3T Achieva scanner, termed “3T ZH,” n ¼
66).17,18 In addition, high-resolution MR imaging scans acquired
on “1.5T VIE” from the previous epilepsy study2 were available,
n ¼ 12. Thus, the healthy control data base comprised a total of
122 subjects (71 women, 41 men; mean age 36.2 6 12.5 years,
range 22–62). The size of the control group was based on previ-
ous work on nonparametric single-subject VBM.7,8
Details of the scanning protocols are given in the On-line
Appendix. All images were examined by a senior neuroradiolo-
gist and only participants without structural abnormalities or
motion artifacts were included. The inclusion of data from differ-
ent scanners was considered helpful for the evaluation of the
method in a real-world setting, where scanners may occasionally
be replaced.
Demographic, Clinical, and Follow-Up Data
Demographic and clinical data and radiologic MR imaging
reports were acquired from electronic charts. Follow-up data
from the patients from the previous epilepsy study2 were col-
lected if available, by using electronic charts from the Medical
University of Vienna, including histology (if the patient had
undergone epilepsy surgery) and seizure outcome according to
the International League Against Epilepsy (ILAE) classification,19
considering seizure control during the last available 12months.
Mean follow-up duration of operated patients was 9.6 6
4.1 years. Detailed histologic reports were collected from operated
patients and retrospectively assigned according to the ILAE clas-
sification scheme for hippocampal sclerosis (HS)20 based on
description of cell loss in the respective subfields.
VBM and Estimation of Hippocampal Gray Matter
Volumes
Images were segmented into gray matter, white matter, and cere-
brospinal fluid with the VBM8 toolbox (http://dbm.neuro.uni-
jena.de/wordpress/vbm/download/), incorporated in the SPM8
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) software
running on Matlab R2008b (MathWorks). The VBM8 toolbox
uses a high-dimensional Diffeomorphic Anatomical Registration
Through Exponentiated Lie Algebra (DARTEL) for optimized
registration of different brains15 to the template brain as a default
setting. The basic idea behind DARTEL is to increase the accuracy
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of intersubject alignment by modeling the shape of each scan
by using millions of parameters (3 per voxel).15 The default
DARTEL-template in VBM8 was used to keep the analysis pipe-
line identical for all subjects, independent from the scanner site.
The sampling distance was set to 1 and the bias regularization to
extremely light, expecting high-intensity nonuniformity artifact;
otherwise default settings were used. The “modulation” procedure
ensures the preservation of volume information after normalization
to the template. The normalized GM segments were smoothed by
using a 6-mm full width at half maximum Gaussian kernel.
Individual MR imaging scans of patients were compared against
the healthy controls from “3T ZH” and “3T VIE” (n ¼ 110), by
using Statistical non Parametric Mapping21 (SnPM, http://www2.
warwick.ac.uk/fac/sci/statistics/staff/academic-research/
nichols/software/snpm), as this approach is less dependent on
normality of data and is less likely to yield false-positives. SnPM is
a toolbox for SPM based on nonparametric permutation testing21
where normality of data and equal variance are not required. This
should be an advantage in unbalanced statistical designs such as
single-case VBM where one subject is compared against a control
group.8 Age, sex, and total intracranial volume (TIV), which is cal-
culated as the sum of GM, white matter, and cerebrospinal fluid by
the VBM toolbox, were used as nuisance variables.
Only voxels in the right or left hippocampus (as defined by
the MarsBaR toolbox http://marsbar.sourceforge.net/about.html)
were considered. The following threshold was defined a priori:
P, .05, corrected for multiple comparisons with family-wise
error, across the ROI right 1 left hippocampus (small volume
correction).
The proportion of patients with known hippocampal atrophy
who had clusters of decreased GM in the respective hippocampus
was calculated (sensitivity). In a second step, in an identical way,
individual MRI of the healthy control group (n¼ 122) was succes-
sively compared against the healthy controls from “3T ZH” and
“3T VIE” (n ¼ 110), to determine specificity (true-negative rate ¼
1 – false-positive rate). Thus, sensitivity and specificity of the volu-
metric approach for the detection of hippocampal atrophy was cal-
culated with 95%Wilson confidence intervals.
Subsequently, GM of the right and left hippocampus was
extracted automatically from individual normalized and smoothed
GM segments by using the MarsBaR toolbox (http://marsbar.
sourceforge.net/). Individual hippocampal volumes for the right
and left sides divided by TIV were plotted against the data from
healthy controls, from which percentiles 5 and 95 were estimated.
The hippocampal volumes in subjects with known hippocampal
sclerosis would be expected to be below percentile 5 of controls,
based on pilot data.
Finally, for quality control, test-retest reliability for extracted
hippocampal volumes was calculated based on scans of healthy
controls who were scanned twice at “3T ZH.” Possible interscan-
ner differences were estimated, comparing right and left hippo-
campal volumes of healthy controls between the 3 scanners by
using MarsBaR.
RESULTS
VBM in Individual Patients and Specificity of Findings
Significant volume decreases are shown in Fig 1 and On-line Fig
1. Results for individual patients including nonparametric t-
FIG 1. Comparison of representative individual patients with right-sided TLE against a normal data base of 110 healthy controls. The color scale
indicates the nonparametric t-value. Results are displayed at P, .05 corrected for multiple comparisons with family-wise error across the ROI.
The scatterplot shows extracted hippocampal volumes/total intracranial volume for controls and patients (y-axis, institutionary units), where
the individual patient is indicated with a blue arrow. Different symbols indicate the control cohorts. The x-axis indicates the age. Blue dotted
lines show percentiles 5 and 95, respectively.
AJNR Am J Neuroradiol 41:987–93 Jun 2020 www.ajnr.org 989
scores are given in the On-line Table. The sensitivity for the
detection of hippocampal sclerosis was 0.92 for the right side and
0.60 for the left, with a high specificity of 0.98 (Table).
Importantly, right-sided hippocampal atrophy could be detected
in 1 patient (P13) in whom routine MR imaging was considered
normal (only fluid attenuated inversion recovery [FLAIR] hyper-
intensity was detected with the automated Morphometric
Analysis Program [MAP]).22 In 4 patients with left-sided hippo-
campal sclerosis, no atrophy could be detected automatically at
this threshold, and 2 of them had only very mild signs of hippo-
campal sclerosis on MR imaging (On-line Table, clinical data).
All clusters of decreased hippocampal volumes were on the side
of the seizure focus.
Extracted Hippocampal Volumes in Patients with
Temporal Lobe Epilepsy
In 12/13 patients with hippocampal sclerosis/atrophy on the right
side, extracted hippocampal volumes/TIV were below percentile
5 ipsilaterally (Fig 1), corresponding to a sensitivity of 0.92 (95%
Wilson CI, 0.67–0.99). The patient with a normal MR imaging
report (P13) and FLAIR hyperintensity in automated postpro-
cessing on the right side had a hippocampal volume/TIV just
below percentile 5. Conversely, in 8/10 patients with hippocampal
sclerosis/atrophy on the left side, hippocampal volumes/TIV
were below percentile 5, corresponding to a sensitivity of 0.80
(0.49–0.94). The 3 cases with left hippocampal volumes/TIV
above percentile 5 had no or only very discrete signs of atrophy
in radiologic reports. Lateralization was correct in all cases (with
low hippocampal volume), ie, the side of low hippocampal vol-
ume/TIV always corresponded to the side of seizure onset.
Receiver operating characteristic curves (ROC) for the detection
of hippocampal atrophy based on extracted hippocampal vol-
umes for the right and left hippocampus are shown in On-line
Fig 2. The area under the curve (AUC) was 0.964 for the right
hippocampus and 0.900 for the left hippocampus, indicating
excellent accuracy. ROC analyses including only subjects from
the scanner 1.5T VIE showed similar AUC values (right hippo-
campus 0.993; left hippocampus 0.898).
Histology from Resected Hippocampal Specimens and
Postsurgical Outcome
Histopathologic results and postsurgical outcome according to
the ILAE classification19 were available in all patients who under-
went epilepsy surgery (n ¼ 20; On-line Table). Radiologic find-
ings of hippocampal sclerosis were confirmed in all operated
cases histologically (On-line Table) as a finding of partial HS
(type 1 in most cases). One case with FLAIR hyperintensity in the
hippocampus and signs of volume increase in automated volume-
try (P25) had no hippocampal sclerosis, but did have discrete dis-
persion of granular cells and reactive oligodendral hyperplasia.
Seventeen out of 19 cases with hippocampal sclerosis on histology
showed decreased hippocampal volume on automated volumetry.
Outcome was favorable in most cases (On-line Table), in accord-
ance with the literature.10
Hippocampal Volumes in Healthy Controls
Left hippocampal volumes were significantly larger compared
with right hippocampal volumes (0.47 6 0.046 versus 0.44 6
0.046; P, .001, paired t-test). Left and right hippocampal vol-
umes/TIV (ratio) showed a significant negative correlation with
age (left: r¼ 0.196, P¼ .031; right: r¼0.361, P, .001).
Test-Retest Reliability
Thirty-seven healthy controls were scanned twice at the 3T ZH,
with a mean time interval of 166.4 6 27.9 days. Extracted hip-
pocampal volumes/TIV were stable between time points, as evi-
denced by good correlations for right (r ¼ 0.95) and left
hippocampal volumes (r ¼ 0.96; On-line Fig 3). In addition, hip-
pocampal volumes were compared between time points on a voxel
basis, by using a paired t-test design within SPM. At the whole
brain level, corrected for multiple comparisons with family-wise
error, no significant differences were found. In ROI analyses, a few
voxels showed decreased gray matter in the region of the right hip-
pocampal tail at the later time point (5 voxels at x ¼ 26, y ¼ 36,
z¼ 7 and 1 voxel at x¼ 23, y¼36, z¼ 4; On-line Fig 3).
Comparisons between Scanners
Hippocampal volumes were compared between healthy controls
scanned with the scanners 3T VIE, 3T ZH, and 1.5T VIE, by using
an ANOVA model within SPM and the MarsBar toolbox, with the
covariates age, sex, and TIV. The Bonferroni correction for multiple
testing was applied. For the left hippocampus, no significant differ-
ences were found between the scanners. Right hippocampal vol-
umes from the 3T ZH were significantly lower compared with
those from the 3T VIE (P, .001, corrected) and 1.5T VIE
(P¼ .001, corrected). In age- and sex-matched healthy controls,
right hippocampal volume was 7.1% lower on data from 3T ZH as
compared with 3T VIE. However, these between scanner effects for
the right hippocampus were considerably lower than the differences
related to hippocampal atrophy in patients (On-line Fig 4).
Sensitivity and specificity of single-subject VBM for the detection of hippocampal atrophy
Sensitivity for the detection of hippocampal
atrophy in patients with mesial temporal
lobe epilepsya
R Hippocampus decrease L Hippocampus decrease
0.92 (0.67–0.99) 0.60 (0.31–0.83)
Specificity of hippocampal volume changes
R Hippocampus L Hippocampus
Decrease Increase Decrease Increase
Specificity 0.99 (0.96–1.00) 1.00 (0.97–1.00) 0.99 (0.96–1.00) 0.99 (0.96–1.00)
Decrease or increase in R or L Hippocampus
Specificity 0.98 (0.93–0.99)
aWilson 95% CI is given in brackets.
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DISCUSSION
Various VBM techniques have been evaluated for the detection
of occult brain lesions in focal epilepsy.23 The present study
focuses on the detection of hippocampal atrophy based on auto-
mated analyses of T1-weighted MR imaging of the brain. Our
study demonstrates that hippocampal atrophy related to mesial
temporal sclerosis can be automatically detected in individual
patients by VBM by using nonparametric statistics with high sen-
sitivity and specificity. Using small volume correction for multi-
ple comparisons, the finding of atrophy was highly specific
(0.99), indicating that this procedure adequately minimizes false-
positives. Furthermore, VBM always correctly lateralized the epi-
leptogenic zone. Our data indicate that this technique should be
useful in clinical practice, because it enables an objective user-in-
dependent measurement of individual atrophy and is less time-
consuming than manual volumetric methods. Likewise, various
automated hippocampal volumetry techniques including the use of
FreeSurfer (http://surfer.nmr.mgh.harvard.edu) and NeuroQuant
(CorTech Labs, San Diego, California) have been proposed to
increase the diagnostic sensitivity for hippocampal sclerosis.24-30 In
one using NeuroQuant, hippocampal asymmetry z scores had the
best sensitivity (86.7%–89.5%) and specificity (92.2%–94.1%) to
discriminate patients with TLE from healthy controls with AUC
values ranging from 0.915–0.939.27 In another study, the combina-
tion of automated hippocampal T2-relaxometry techniques with
volumetry has been shown to improve separation of patients with
HS from healthy controls.31 Similarly, an automated volumetry
and FLAIR analysis tool improved the diagnosis of ambiguous
HS.32 Huppertz et al33 showed that an automated quantitative
FLAIR analysis in SPM could assist the diagnosis of hippocampal
sclerosis with high sensitivity (97.1%) and specificity (95.4%).
In contrast to these studies that primarily analyzed estimates
of hippocampal volumes, the present work is focused on auto-
mated voxel-based analyses, providing topographic information
on atrophy patterns. Voxel-based techniques have rarely been
used for the individual diagnosis of hippocampal sclerosis.
Bonilha et al12 demonstrated voxelwise standardized z scores to
be helpful for the detection of hippocampal sclerosis (with an
AUC of 0.973) and more recently, machine-learning techniques
have been used to discriminate right or left mesial TLE from
healthy controls.13,14 Our findings contrast with one previous
study that found VBM not to be sensitive for the detection of hip-
pocampal sclerosis and neuronal loss in individual patients.11
Methodologic issues such as improved preprocessing by using
high-dimensional warping, the use of nonparametric statistics,
and a large control group probably can explain this discrepancy.
One previous study on healthy controls showed that the high rate
of false-positives frequently observed in single-subject VBM stud-
ies7 can be minimized by using nonparametric statistics, which is
not based on the assumption of normal distribution and equal
variance.8 By comparing 122 individual healthy controls succes-
sively against the healthy control group, we confirmed a low
false-positive rate (2%), ie, high specificity (0.98), as long as cor-
rection for multiple testing was applied. Conversely, correction
for multiple comparisons across the whole brain may be too con-
servative, when the main interest lies on hippocampal structures
and we propose an a priori-defined small volume correction to be
optimal in this case. Extracting hippocampal volumes and com-
paring these to normal values can further strengthen the detec-
tion of atrophy in individual patients.
As right and left hippocampal volumes significantly differed
in favor of the left side in healthy controls, it is mandatory to esti-
mate normal ranges separately for both sides. Asymmetry of
mesial temporal lobe structures (left . right), including the hip-
pocampal formation, has been found in an earlier VBM study on
a large group of healthy controls.34 Although, this may depend
on analysis techniques, because the reverse asymmetry has also
been reported by using NeuroQuant27 or FreeSurfer.24 Right and
left hippocampus showed only a slight decrease with age in con-
trast to an obvious total gray matter volume loss (data not
shown), corroborating previous findings indicating that the hip-
pocampus may be relatively spared from volume loss over a wide
age range in healthy controls.35
For quality control, additional analyses in healthy controls were
conducted, considering reproducibility of volumetric measurements
and possible variability between MR imaging scanners. As 37
healthy controls were scanned twice with the 3T ZH, test-retest reli-
ability could be calculated and was considered excellent, with r-val-
ues ranging from 0.95–0.96 for extracted hippocampal volumes.
Voxel-based comparisons between time points showed no signifi-
cant differences between time points at whole brain level; however,
ROI analyses for the right and left hippocampus revealed a few vox-
els with reduced gray matter in the region of the right hippocampal
tail at the later time point. These were considered unlikely to have an
influence on the results because of the distinct anatomic localization.
The present study used MR imaging data from 3 different
scanners, two 3T scanners of the same type (3T VIE and 3T ZH,
both Achieva) and one 1.5T scanner from the same manufacturer
(1.5T VIE, Gyroscan). Motivation for this approach was the
assumption that a large control group would ultimately increase
the sensitivity for alterations in individual patients. In addition, a
large control group of n ¼ 198 was also used in the study of
Scarpazza et al8 on nonparametric VBM. Furthermore, MR imag-
ing scanners are being replaced from time to time, so that data
from different machines may be collected when a rare condition
is to be studied over a longer time period. Finally, multicenter
MR imaging studies may be an emerging strategy in the study of
rare disorders. In our study, a scanner effect was seen only for the
right hippocampus with decreased volume estimates for data
from 3T ZH. This possibly decreased the sensitivity for the detec-
tion of right HS, because a large portion of the healthy controls
was investigated at this site. Ultimately, interscanner effects could
not be exactly determined, because different subjects were
scanned in Vienna and in Zurich. However, in the between-scan-
ners analyses, sex and age were used as nuisance variables, so that
these finding should not be confounded by demographic variabil-
ity. Age- and sex-matched comparisons of mean hippocampal
volumes confirmed lower hippocampal volumes in subjects
scanned with 3T ZH compared with 3T VIE (7.1% lower);
whereas comparisons with 1.5T VIE were not significant after
correction for multiple comparisons, but this sample was rather
small (n¼ 11, data not shown).
The variability of automated volumetric measurements between
scanners has previously been estimated to range up to 14.7%
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(coefficient of variation) depending on the structures studied.36Our
data indicate, however, that the volumetric changes detected in hip-
pocampal sclerosis clearly outweigh interscanner differences (On-
line Fig 4). Thus, combining data from different scanners may be
feasible when the expected disease-related effects are expected to
exceed the interscanner variability. Interestingly, intersite effects for
various MR imaging measures including gray matter volume have
been observed even after harmonizing imaging protocols.37
Nevertheless, harmonization of scanning protocols and equipment
should be attempted whenever possible.
In the present study, hippocampal sclerosis could be verified
by histology in most cases. This suggests in vivo determined vol-
ume decrease to be associated with cell loss in the case of hippo-
campal sclerosis, though this could not be shown directly in our
study. Histologic sections were not available for quantitative anal-
ysis and thus, no correlations between MR imaging derived hip-
pocampal volume and histologic measures such as cell size or
attenuation could be performed. Hippocampal subfield volumes
estimated by a manual segmentation approach have been shown
to correlate with neural attenuation and size derived from histol-
ogy.38 Likewise, automatically estimated total hippocampal vol-
umes were correlated with histopathologic neural attenuation in
the hippocampus and its subfields.39
Most of the operated cases were considered to have type 1 HS,
which is the most abundant form with good prognosis.20,40 Our
data indicate that automated detection of volume decrease related
to HS is probably not confined to this subtype as a few subjects
with type 2 or 3 HS also showed significant atrophy.
Previous studies have consistently shown atrophy in patients
with mesial TLE beyond the hippocampus in regions anatomically
and functionally related, such as thalamus and cingulum, ie, net-
work atrophy,2-4,41 based on group comparisons. The nonparamet-
ric approach of the present study may have the potential to
identify network atrophy on an individual level though sensitivity
and specificity of findings would have to be thoroughly assessed
across regions. Thus, the prevalence of atrophy in particular
regions could be estimated, which is probably of interest for our
understanding of TLE.42 This was, however, beyond the scope of
our study, and further work on this issue will be necessary.
As a limitation of the present study, it has to be mentioned that
the sensitivity and specificity of findings apply exclusively to the
hippocampus that has been analyzed; findings may differ for other
regions in terms of false-positives,7 depending also on region-spe-
cific smoothness of data. The present study did not evaluate the
proposed analysis pipeline for discrimination between mesial TLE
and other forms of epilepsy. Another limitation is the pooling of
MR imaging data from different sites without harmonization of
study protocols and equipment, inherent in the retrospective design.
Further, in the present study, no direct comparisons between hip-
pocampal volume and histologic measures could be performed.
Finally, it has to be acknowledged that hippocampal volume loss is
only one of the hallmarks of hippocampal sclerosis, where hyperin-
tensity on FLAIR and T2-weighted images, loss of internal struc-
ture, as well as changes on diffusion tensor imaging may also be
considered.25,43 It should also be emphasized that the presented
analysis pipeline is meant to assist neuroradiologists¨ and clinicians¨
work in the context of dedicated radiologic and clinical evaluation.
Strengths of the present study include the well-characterized
group of patients with epilepsy with histologic and long-term fol-
low-up data and the large number of healthy controls being subse-
quently and individually compared with the control group. SPM
and its toolboxes are freely available, which could encourage the
clinical application of VBM for volumetry. Required computa-
tional resources were considered within acceptable limits because
processing time per image was approximately 50minutes.
CONCLUSIONS
Although reproducibility and specificity of findings from VBM
studies have been a matter of debate, our findings show that non-
parametric VBM is sensitive and specific for hippocampal atro-
phy in patients with mesial TLE, and we encourage its use in
clinical practice. Further, we provide evidence that MR imaging
data from different centers may be combined for morphometric
studies if gross structural abnormalities are expected. The impor-
tance of harmonization of MR imaging scanning protocols and
equipment should be considered in future prospective studies.
Lastly, because VBM can provide information on whole-brain
topographic changes, future studies could investigate individual
atrophy patterns in TLE.
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